Medipower (Overseas) Public Co. Limited (TLV:MDPR)
Israel · Delayed Price · Currency is ILS · Price in ILA 666.90
+41.50 (6.64%)
Jul 30, 2026, 5:24 PM IDT
TLV:MDPR Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Property, Plant & Equipment | 638.81 | 444.12 | 388.5 | 384.45 | 377.62 | 356.35 |
Cash & Equivalents | 34.65 | 73.05 | 5.64 | 5.33 | 7.04 | 4.09 |
Accounts Receivable | 1.39 | 1.3 | 1.55 | 1.93 | 1.26 | 1.56 |
Other Receivables | 3.29 | 0.07 | 2.57 | 0.01 | 0.02 | 0.01 |
Investment In Debt and Equity Securities | 7.9 | 7.9 | 7.5 | 8.6 | 6.73 | - |
Loans Receivable Current | 0.61 | 0.77 | 1.67 | 3.61 | 5.27 | 0.01 |
Restricted Cash | - | - | - | - | 6.6 | - |
Other Current Assets | 1.79 | 4.64 | 1.69 | 5.82 | 7.56 | 33.33 |
Other Long-Term Assets | 15.45 | 16.72 | 7.31 | 6.82 | 8.58 | 7.67 |
Total Assets | 703.89 | 548.58 | 416.43 | 416.57 | 420.7 | 403.02 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Current Portion of Long-Term Debt | 23.63 | 29.11 | 11.46 | 20.26 | 17.71 | 13.6 |
Long-Term Debt | 444.7 | 322.49 | 232.52 | 236.27 | 251.22 | 244.95 |
Accrued Expenses | - | 3.96 | 1.95 | 1.83 | 2.72 | 2.11 |
Current Income Taxes Payable | - | - | 0 | 0.05 | 1.32 | 0.13 |
Other Current Liabilities | 9.56 | 3.49 | 2.88 | 3.79 | 3.37 | 18.62 |
Long-Term Deferred Tax Liabilities | 22.26 | 22.02 | 16.08 | 13 | 12.16 | 12.38 |
Total Liabilities | 500.14 | 381.06 | 264.9 | 275.21 | 288.49 | 291.8 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 5.11 | 5.11 | 5.11 | 5.11 | 5.11 | 4.46 |
Additional Paid-In Capital | 69.54 | 69.48 | 69.28 | 69.09 | 68.9 | 55.97 |
Retained Earnings | 67.23 | 67.69 | 55.25 | 45.07 | 37.07 | 35.72 |
Comprehensive Income & Other | 4.04 | 4.06 | 3.63 | 4.33 | 3.14 | -0.48 |
Total Common Equity | 145.92 | 146.35 | 133.27 | 123.6 | 114.22 | 95.67 |
Minority Interest | 57.83 | 21.16 | 18.27 | 17.76 | 17.99 | 15.56 |
Shareholders' Equity | 203.75 | 167.51 | 151.54 | 141.36 | 132.2 | 111.22 |
Total Liabilities & Equity | 703.89 | 548.58 | 416.43 | 416.57 | 420.7 | 403.02 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 468.33 | 351.6 | 243.98 | 256.53 | 268.93 | 258.55 |
Net Cash (Debt) | -433.68 | -278.55 | -238.34 | -251.21 | -261.88 | -254.46 |
Net Cash (Debt) Growth | - | - | - | - | - | - |
Net Cash Per Share | -8.48 | -5.45 | -4.66 | -4.91 | -5.16 | -6.06 |
Filing Date Shares Outstanding | 51.14 | 51.14 | 51.14 | 51.14 | 51.14 | 51.14 |
Total Common Shares Outstanding | 51.14 | 51.14 | 51.14 | 51.14 | 51.14 | 51.14 |
Book Value Per Share | 2.85 | 2.86 | 2.61 | 2.42 | 2.23 | 1.87 |
Tangible Book Value | 145.92 | 146.35 | 133.27 | 123.6 | 114.22 | 95.67 |
Tangible Book Value Per Share | 2.85 | 2.86 | 2.61 | 2.42 | 2.23 | 1.87 |